SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-20-010241
Filing Date
2020-03-12
Accepted
2020-03-12 07:00:57
Documents
3
Period of Report
2020-03-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K_EARNINGS RELEASE Q1 2020 itrm-8k_20200312.htm 8-K 34300
2 EX-99.1 itrm-ex991_9.htm EX-99.1 216102
3 GRAPHIC gkpycmvls51m000001.jpg GRAPHIC 8081
  Complete submission text file 0001564590-20-010241.txt   262954
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 20707129
SIC: 2834 Pharmaceutical Preparations